Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis - Test2 - elhamkhani - TriplyDB

Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis

Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis

http://www.wikidata.org/entity/Q28384019

about

Asymmetric dimethylarginine levels in patients with cutaneous anthrax: a laboratory analysis

http://www.wikidata.org/entity/Q28384019

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@ast

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@en

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@nl

type

label

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@ast

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@en

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@nl

prefLabel

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@ast

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@en

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@nl

P1433

Q28384019-6C2A2671-A23F-4B48-8F0B-55533EBE03DF

P1476

Q28384019-58C29BBF-5947-4106-B11C-D77F45634D4F

P2093

Q28384019-0E04845F-805C-4BFC-99DA-725F517E7264

Q28384019-14AFBFD4-9C4B-4329-8BBD-FBEF5C1DED2E

Q28384019-24F2958C-8EB0-47AB-8B16-033B283DCC5B

Q28384019-6559820D-7F97-43BE-A0ED-8EA7F14EDC13

Q28384019-754F49E8-C2DA-448D-A42A-5F264BD06D2F

Q28384019-B0280640-0860-4F91-8A01-3E88533C32DA

Q28384019-C04EDE86-1A70-4FD7-83DC-9BBCB68ED3F0

Q28384019-E303420F-09E1-480F-A44B-79142C857182

Q28384019-E72BC570-0F6D-4D80-82F0-58401FBE21C8

P2860

Q28384019-04379514-CC53-494F-A952-D58E8D794944

Q28384019-06F5E2AF-056A-4E6D-9F1E-6EC6CB29201F

Q28384019-0969F91A-EE0D-4273-BB64-6372AF342245

Q28384019-178281DC-4A65-4666-B0CB-70988854F2A3

Q28384019-2E8BF865-32C2-4914-8AB9-A97E32449C2B

Q28384019-3066B118-F1EF-4840-B6C0-F14A9E530B66

Q28384019-357F853C-BD31-469C-95B4-13C7201F6552

Q28384019-4BF69256-04CF-49AE-80B3-9D3C39DAD2B7

Q28384019-508287C8-1E73-4CA5-B35A-59A46409B3B4

Q28384019-71E54172-E1C9-432D-9971-15B24A8CB14D

P2888

Q28384019-E26D83F0-6662-42F5-845F-B992BB13E2BA

P304

Q28384019-D79B3FA8-BD83-4373-923D-513A1B392426

P31

Q28384019-CF5887E0-3556-4972-BBA7-30AFB0779295

P356

Q28384019-20B92E7C-B742-42C0-8176-01890E004158

P407

Q28384019-F1ED71DE-2BA4-4BAF-BE3B-E70DC90D7236

P433

Q28384019-BB71723B-A109-4029-9D04-ECB4141651CC

P478

Q28384019-41D36C78-9511-44B6-B276-F8AAF5EA856E

P577

Q28384019-B9F28AC6-B92A-43BD-ADCB-CE7890CADA58

P5875

Q28384019-D2A88100-8185-4C8F-8664-0416AA25DE75

P6179

Q28384019-BADB81A9-B2D0-48AC-9FA1-F2C97B64F1EE

P698

Q28384019-7CA9BE7C-E300-462D-9E7A-269A7C524FBF

P921

Q28384019-F9BAADD8-888F-4CA0-A15C-2AE6D4852F70

P932

Q28384019-CD9A4457-5578-437C-8511-BF09C77A6894

P356

1476-0711-13-12

P1433

Annals of Clinical Microbiology and Antimicrobials

P1476

Asymmetric dimethylarginine le ...... anthrax: a laboratory analysis

@en

P2093

Abdulkadir Kucukbayrak

http://www.w3.org/2001/XMLSchema#string

Ali Irfan Baran

http://www.w3.org/2001/XMLSchema#string

Cenk Aypak

http://www.w3.org/2001/XMLSchema#string

Hayrettin Akdeniz

http://www.w3.org/2001/XMLSchema#string

Mahmut Sunnetcioglu

http://www.w3.org/2001/XMLSchema#string

Mehmet Resat Ceylan

http://www.w3.org/2001/XMLSchema#string

Mehmet Tosun

http://www.w3.org/2001/XMLSchema#string

Mustafa Karahocagil

http://www.w3.org/2001/XMLSchema#string

Zafer Mengeloglu

http://www.w3.org/2001/XMLSchema#string

P2860

Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings

Bench-to-bedside review: endothelial cell dysfunction in severe sepsis: a role in organ dysfunction?

Nitric oxide: physiology, pathophysiology, and pharmacology

The critical role of pathology in the investigation of bioterrorism-related cutaneous anthrax

Anthrax lethal toxin induces endothelial barrier dysfunction

Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study.

Cutaneous manifestations of anthrax in Eastern Anatolia: a review of 39 cases.

Reducing ventilator-induced lung injury and other organ injury by the prone position.

Live and let die: asymmetric dimethylarginine and septic shock.

Time course of endogenous nitric oxide inhibitors in severe sepsis in humans.

P2888

1476-0711-13-12

P304

12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-0711-13-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261137259

http://www.w3.org/2001/XMLSchema#string

P6179

1003175943

http://www.w3.org/2001/XMLSchema#string

P698

24669818

http://www.w3.org/2001/XMLSchema#string

P921

infectious disease

P932

3986940

http://www.w3.org/2001/XMLSchema#string